Biomarkers To Make A Stellar Contribution To The Glycated Haemoglobin Testing Market

The report pinpoints and analyzes each and every aspect that could influence demand within glycated hemoglobin testing market over the forecast period. Vital market indicators, demand dynamics, and competitive outlook are some aspects that are examined for valuable insights into the growth curve of glycated hemoglobin testing market in the forthcoming years.

The novel disposable device draws blood painlessly for accurate measurement of glycated hemoglobin levels in individuals with diabetes.

By function, the single-use, small push-button device first sucks, cumulates, and stabilizes a capillary blood sample from the upper arm. Following this, blood is gently collected via the skin using minuscule lancets and light vacuum suction. The apparatus omits the need of use of invasive hyppdermic needle to puncture a vein.

For the examination part, the blood sample is stabilized on a paper matrix filter and held within a removable cartridge. The matrix filter is designed to protect the sample for safe transportation until it reaches a certified clinical laboratory for complete measurement of glycated hemoglobin levels.

Prominent companies operating in the glycated hemoglobin testing market include Abbott Laboratories, Alere Inc., Bio-Rad Laboratories Inc., ARKAY Inc., Tosoh Corp., Beckman Coulter Inc., Roche Holdings AG, Bayer AG, Randox Laboratories Ltd., and A. Menarini Diagnostics Ltd.

Availability of point-of-care HbA1c testing devices is serving to boost uptake of glycated hemoglobin testing market. Regulatory approval received by some point-of-care HbA1C testing devices boosts consumer confidence for these devices.

However, on the downside, risk of flawed results of point-of-care testing is leading to dwindling demand for glycated hemoglobin testing tools. Besides this, none point-of-care HbA1c testing devices have so far not received FDA clearance for the diagnosis of type 2 diabetes.

According to guidelines from an International Expert Committee for glycated hemoglobin testing, the latter is indicated as an alternative diagnostic tool, but not superior to blood glucose testing for diabetes management. This hampers growth of glycated hemoglobin testing market.

Pre-Book Right Now for Exclusive Analyst Support@ https://www.persistencemarketresearch.com/checkout/3219